BRIEF-Neurocrine Biosciences Q3 Adjusted EPS USD 3.29 Vs. IBES Estimate USD 1.91
Reuters2026/11/02 21:51By:Reuters
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Nov 02 (Reuters) - Neurocrine Biosciences Q3 net income USD 207 million.
- Q3 adjusted net income USD 347 million vs. IBES estimate USD 203.8 million
- Q3 EPS USD 1.96
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Algonquin Power & Utilities Corp. Price Target Cut to $7.00/Share From $7.25 by Raymond James
Dow Jones•2026/11/09 15:45
Docebo Inc. Price Target Raised to $36.00/Share From $28.00 by Stifel
Dow Jones•2026/11/09 15:45
Algonquin Power & Utilities Corp. Is Maintained at Market Perform by BMO
Dow Jones•2026/11/09 15:44
AMEX HALT <MPWC.A> ADD INFO LST 16.744500
Reuters•2026/11/09 15:40
Crypto prices
More
Bitcoin
BTC
$74,691.84
-1.30%
Ethereum
ETH
$2,122.54
-4.71%
Tether USDt
USDT
$0.9991
+0.04%
BNB
BNB
$685.34
-1.39%
USDC
USDC
$0.9999
+0.02%
XRP
XRP
$1.09
-5.25%
Solana
SOL
$86.44
-2.81%
TRON
TRX
$0.3170
-0.91%
Zcash
ZEC
$1,167.18
-6.41%
Hyperliquid
HYPE
$74.74
-2.27%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now